Development and application of a next-generation-sequencing (NGS) approach to detect known and novel gene defects underlying retinal diseases

Abstract : Background
Inherited retinal disorders are clinically and genetically heterogeneous with more than 150 gene defects accounting for the diversity of disease phenotypes. So far, mutation detection was mainly performed by APEX technology and direct Sanger sequencing of known genes. However, these methods are time consuming, expensive and unable to provide a result if the patient carries a new gene mutation. In addition, multiplicity of phenotypes associated with the same gene defect may be overlooked.
Methods
To overcome these challenges, we designed an exon sequencing array to target 254 known and candidate genes using Agilent capture. Subsequently, 20 DNA samples from 17 different families, including four patients with known mutations were sequenced using Illumina Genome Analyzer IIx next-generation-sequencing (NGS) platform. Different filtering approaches were applied to identify the genetic defect. The most likely disease causing variants were analyzed by Sanger sequencing. Co-segregation and sequencing analysis of control samples validated the pathogenicity of the observed variants.
Results
The phenotype of the patients included retinitis pigmentosa, congenital stationary night blindness, Best disease, early-onset cone dystrophy and Stargardt disease. In three of four control samples with known genotypes NGS detected the expected mutations. Three known and five novel mutations were identified in NR2E3, PRPF3, EYS, PRPF8, CRB1, TRPM1 and CACNA1F. One of the control samples with a known genotype belongs to a family with two clinical phenotypes (Best and CSNB), where a novel mutation was identified for CSNB. In six families the disease associated mutations were not found, indicating that novel gene defects remain to be identified.
Conclusions
In summary, this unbiased and time-efficient NGS approach allowed mutation detection in 75% of control cases and in 57% of test cases. Furthermore, it has the possibility of associating known gene defects with novel phenotypes and mode of inheritance.
Type de document :
Article dans une revue
Orphanet Journal of Rare Diseases, BioMed Central, 2012, 7 (1), pp.8. 〈10.1186/1750-1172-7-8〉
Liste complète des métadonnées

Littérature citée [75 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00697616
Contributeur : Ed. Bmc <>
Soumis le : mardi 15 mai 2012 - 17:03:34
Dernière modification le : mercredi 21 mars 2018 - 18:57:36
Document(s) archivé(s) le : vendredi 30 novembre 2012 - 11:45:49

Fichiers

1750-1172-7-8.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Isabelle Audo, Kinga Bujakowska, Thierry Léveillard, Saddek Mohand-Saïd, Marie-Elise Lancelot, et al.. Development and application of a next-generation-sequencing (NGS) approach to detect known and novel gene defects underlying retinal diseases. Orphanet Journal of Rare Diseases, BioMed Central, 2012, 7 (1), pp.8. 〈10.1186/1750-1172-7-8〉. 〈inserm-00697616〉

Partager

Métriques

Consultations de la notice

389

Téléchargements de fichiers

275